Our mission at MiroBio is to develop novel, best-in-class therapeutics that bring significant benefits to patients suffering from a range of auto-immune diseases. MiroBio's medicines will activate natural mechanisms to regain control of over-active immune responses triggering these diseases.
MiroBio's platform is based on ground-breaking research by our scientific founders at the University of Oxford delineating how immune cells communicate and how they are activated. These insights have enabled MiroBio to create antibodies that can leverage natural signalling mechanisms to restore immune system balance and control.
Our growing team of dedicated scientists, experienced executives, and advisers, backed by international life sciences investors, is focused on applying the fundamental principles of immune control to discover and advance safe, efficacious treatments for these debilitating diseases.